The BC Cancer Library
Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Table of Contents; 1: INTRODUCTION TO DOSING MEDICATIONS IN OBESE PATIENTS; 2: ANTIMICROBIAL DOSING IN OBESITY; 3: ANTICOAGULANTS AND ANTIPLATELETS; 4: CRITICAL CARE; 5: ANTIEPILEPTICS; 6: DOSING ANTINEOPLASTIC MEDICATIONS IN OBESE PATIENTS; 7: PEDIATRICS; 8: IMMUNOSUPPRESSION DOSING IN OBESE SOLID…
Contents:; Chronic Pain and Opioids -- Current Cost of the Opioid Epidemic -- Opioid Use Disorder -- History and Legality of Cannabis -- Overview of the Endocannabinoid System (ECS) -- Cannabinoids and Terpenes -- Synthetic Cannabinoid Pharmaceuticals -- Isolate Cannabinoid Pharmaceuticals -- Medic…
| c.1 BC Cancer Agency ARHCC Library | Available | ||
| c.1 BC Cancer Agency VAN Library | Available | ||
| c.1 BC Cancer Agency VIC Library | Available |
| c.1 BC Cancer Agency KEL Library | Available |
| c.1 BC Cancer Agency SUR Library | Available |
PART I: INTRODUCTION AND BACKGROUND; 1 INTRODUCTION; 2 CANNABIS; 3 CANNABIS: PREVALENCE OF USE, REGULATION, AND CURRENT POLICY LANDSCAPE; PART II: THERAPEUTIC EFFECTS; 4 THERAPEUTIC EFFECTS OF CANNABIS AND CANNABINOIDS; PART III: OTHER HEALTH EFFECTS; 5 CANCER; 7 RESPIRATORY DISEASE; 8 IMMUNITY; 9…
An animated, educational Web tutorial for cancer health professionals who wish to learn more about targeted cancer therapies
Table of Contents:; I BASIC PRINCIPLES AND CONSIDERATIONS OF RATIONAL CHEMOTHERAPY AND MOLECULAR TARGETED THERAPY -- BIOLOGIC AND PHARMACOLOGIC BASIS OF CANCER CHEMOTHERAPY --BIOLOGIC BASIS OF MOLECULAR TARGETED THERAPY -- PRINCIPLES OF CANCER IMMUNOTHERAPY -- SYSTEMATIC ASSESSMENT OF THE PATIENT W…
| c.1 BC Cancer Agency VAN Library | Available |
Table of Contents:; Cover -- Preface -- Contents -- Executive Summary -- 1. Introduction -- 1.1 Low Doses and Low Dose Rates -- 1.2 Use of Radiation Biology Data to Reduce the Uncertainty in Risk Estimates -- 2. General Approaches to Risk Assessment -- 2.1 Risk Assessment Process and Associated Unc…
Contents:; Biologics and the need for biosimilars -- Why do we need biosimilars? -- How is the quality of biosimilar medicines assured? -- Legal issues -- Switching, interchangeability and extrapolation -- Safety and pharmacovigilant -- Global issues -- Formulary considerations: pharmacy issues -- …
